Recent Advances in Nanomedicine for Ocular Fundus Neovascularization Disease Management (Adv. Healthcare Mater. 17/2024)
Yifan Zhou(Second Affiliated Hospital of Zhejiang University), Juan Ye(First People's Hospital of Yuhang District), Wenyue Shen(Second Affiliated Hospital of Zhejiang University), An Shao, Mingyu Xu(Second Affiliated Hospital of Zhejiang University), Haijie Han(Second Affiliated Hospital of Zhejiang University), Yufeng Xu(Integrated Chinese Medicine (China)), Ke Yao(Second Affiliated Hospital of Zhejiang University), Peifang Xu(University of Science and Technology of China)
Cited by 2
Related Papers
Artificial intelligence and deep learning in ophthalmology: Current status and future perspectives
|Advances in Ophthalmology Practice and Research|2022|110
PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation
|Theranostics|2020|79
Nanoceria-Mediated Cyclosporin A Delivery for Dry Eye Disease Management through Modulating Immune–Epithelial Crosstalk
|ACS Nano|2024|67
Biologically inspired bioactive hydrogels for scarless corneal repair
|Science Advances|2024|49
Bacillus as a potential diagnostic marker for yellow tongue coating
|Scientific Reports|2016|46